antinfκb Search Results


antibodies anti-nfκb  (MBL International)
90
MBL International antibodies anti-nfκb
Antibodies Anti Nfκb, supplied by MBL International, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antinf%CE%BAb/anti+nf%CE%BAb/pm24601699-37-14-27
Average 90 stars, based on 1 article reviews
antibodies anti-nfκb - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
antibodies against p-nfκb p65 p-iκbα  (Bioworld Antibodies)
90
Bioworld Antibodies antibodies against p-nfκb p65 p-iκbα
Antibodies Against P Nfκb P65 P Iκbα, supplied by Bioworld Antibodies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antinf%CE%BAb/anti++nf%CE%BAb+p65++bs9879m++antibody/pmc05532290-203-5-9
Average 90 stars, based on 1 article reviews
antibodies against p-nfκb p65 p-iκbα - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
anti-nfκb(p105)(ser932  (ELK Biotechnology)
90
ELK Biotechnology anti-nfκb(p105)(ser932
Effect of paroxetine on ISO-induced NF-κB and inflammatory biomarkers. ( A ) Level of <t>NFκB(p105)</t> in myocardium tissues increased with ISO treatment (CH group) and was prevented by paroxetine pre-treatment (CH + P group) ( n = 6 per group). Serum levels of inflammatory biomarkers IL6 ( n = 4) ( B ) and CRP ( n = 6) ( C ) increased with ISO treatment (CH group) and were prevented by paroxetine and fluoxetine pre-treatment (CH + P and CH + F groups). All data are expressed as mean ± SEM. Differences between groups were detected using one-way ANOVA followed by Dunnett’s post hoc test. Statistically significant differences between groups are shown as * p < 0.05, *** p < 0.001. CH: cardiac hypertrophy untreated; CH + P: cardiac hypertrophy pretreated with paroxetine; CH + F: cardiac hypertrophy pretreated with fluoxetine; NFκB: Nuclear factor-kappa-light-chain-enhancer of activated B-cells; IL6: interleukin 6; CRP: C-reactive protein.
Anti Nfκb(p105)(Ser932, supplied by ELK Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antinf%CE%BAb/anti+nf%CE%BAb+p105++ser932/pmc10743803-201-28-30
Average 90 stars, based on 1 article reviews
anti-nfκb(p105)(ser932 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
anti-nfκb (purified mouse anti- nf-κb colne20/p65  (Becton Dickinson)
90
Becton Dickinson anti-nfκb (purified mouse anti- nf-κb colne20/p65
Effect of paroxetine on ISO-induced NF-κB and inflammatory biomarkers. ( A ) Level of <t>NFκB(p105)</t> in myocardium tissues increased with ISO treatment (CH group) and was prevented by paroxetine pre-treatment (CH + P group) ( n = 6 per group). Serum levels of inflammatory biomarkers IL6 ( n = 4) ( B ) and CRP ( n = 6) ( C ) increased with ISO treatment (CH group) and were prevented by paroxetine and fluoxetine pre-treatment (CH + P and CH + F groups). All data are expressed as mean ± SEM. Differences between groups were detected using one-way ANOVA followed by Dunnett’s post hoc test. Statistically significant differences between groups are shown as * p < 0.05, *** p < 0.001. CH: cardiac hypertrophy untreated; CH + P: cardiac hypertrophy pretreated with paroxetine; CH + F: cardiac hypertrophy pretreated with fluoxetine; NFκB: Nuclear factor-kappa-light-chain-enhancer of activated B-cells; IL6: interleukin 6; CRP: C-reactive protein.
Anti Nfκb (Purified Mouse Anti Nf κb Colne20/P65, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antinf%CE%BAb/anti+nf%CE%BAb++purified+mouse+anti++nf+%CE%BAb+colne20+p65/pmc07609948-68-49-55
Average 90 stars, based on 1 article reviews
anti-nfκb (purified mouse anti- nf-κb colne20/p65 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
rabbit anti-nfκb-p65 (acetyl-k-310)  (ImmunoReagents inc)
90
ImmunoReagents inc rabbit anti-nfκb-p65 (acetyl-k-310)
Effect of paroxetine on ISO-induced NF-κB and inflammatory biomarkers. ( A ) Level of <t>NFκB(p105)</t> in myocardium tissues increased with ISO treatment (CH group) and was prevented by paroxetine pre-treatment (CH + P group) ( n = 6 per group). Serum levels of inflammatory biomarkers IL6 ( n = 4) ( B ) and CRP ( n = 6) ( C ) increased with ISO treatment (CH group) and were prevented by paroxetine and fluoxetine pre-treatment (CH + P and CH + F groups). All data are expressed as mean ± SEM. Differences between groups were detected using one-way ANOVA followed by Dunnett’s post hoc test. Statistically significant differences between groups are shown as * p < 0.05, *** p < 0.001. CH: cardiac hypertrophy untreated; CH + P: cardiac hypertrophy pretreated with paroxetine; CH + F: cardiac hypertrophy pretreated with fluoxetine; NFκB: Nuclear factor-kappa-light-chain-enhancer of activated B-cells; IL6: interleukin 6; CRP: C-reactive protein.
Rabbit Anti Nfκb P65 (Acetyl K 310), supplied by ImmunoReagents inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antinf%CE%BAb/rabbit+anti+nf%CE%BAb+p65++acetyl+k+310+/pmc02631959-94-56-37
Average 90 stars, based on 1 article reviews
rabbit anti-nfκb-p65 (acetyl-k-310) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
anti-nfκb  (GeneTex)
90
GeneTex anti-nfκb
Effect of paroxetine on ISO-induced NF-κB and inflammatory biomarkers. ( A ) Level of <t>NFκB(p105)</t> in myocardium tissues increased with ISO treatment (CH group) and was prevented by paroxetine pre-treatment (CH + P group) ( n = 6 per group). Serum levels of inflammatory biomarkers IL6 ( n = 4) ( B ) and CRP ( n = 6) ( C ) increased with ISO treatment (CH group) and were prevented by paroxetine and fluoxetine pre-treatment (CH + P and CH + F groups). All data are expressed as mean ± SEM. Differences between groups were detected using one-way ANOVA followed by Dunnett’s post hoc test. Statistically significant differences between groups are shown as * p < 0.05, *** p < 0.001. CH: cardiac hypertrophy untreated; CH + P: cardiac hypertrophy pretreated with paroxetine; CH + F: cardiac hypertrophy pretreated with fluoxetine; NFκB: Nuclear factor-kappa-light-chain-enhancer of activated B-cells; IL6: interleukin 6; CRP: C-reactive protein.
Anti Nfκb, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antinf%CE%BAb/anti+nf%CE%BAb/pm32027183-123-34-35
Average 90 stars, based on 1 article reviews
anti-nfκb - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
nfkb p65 polyclonal antibody  (Bioss)
95
Bioss nfkb p65 polyclonal antibody
Effect of paroxetine on ISO-induced NF-κB and inflammatory biomarkers. ( A ) Level of <t>NFκB(p105)</t> in myocardium tissues increased with ISO treatment (CH group) and was prevented by paroxetine pre-treatment (CH + P group) ( n = 6 per group). Serum levels of inflammatory biomarkers IL6 ( n = 4) ( B ) and CRP ( n = 6) ( C ) increased with ISO treatment (CH group) and were prevented by paroxetine and fluoxetine pre-treatment (CH + P and CH + F groups). All data are expressed as mean ± SEM. Differences between groups were detected using one-way ANOVA followed by Dunnett’s post hoc test. Statistically significant differences between groups are shown as * p < 0.05, *** p < 0.001. CH: cardiac hypertrophy untreated; CH + P: cardiac hypertrophy pretreated with paroxetine; CH + F: cardiac hypertrophy pretreated with fluoxetine; NFκB: Nuclear factor-kappa-light-chain-enhancer of activated B-cells; IL6: interleukin 6; CRP: C-reactive protein.
Nfkb P65 Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antinf%CE%BAb/NFKB+p65+Polyclonal+Antibody/custom%40bs-0465r%4036660723
Average 95 stars, based on 1 article reviews
nfkb p65 polyclonal antibody - by Bioz Stars, 2026-08
95/100 stars
  Buy from Supplier
mouse monoclonal anti–nfκb p65-subunit antibody  (Chemicom Inc)
90
Chemicom Inc mouse monoclonal anti–nfκb p65-subunit antibody
Effect of paroxetine on ISO-induced NF-κB and inflammatory biomarkers. ( A ) Level of <t>NFκB(p105)</t> in myocardium tissues increased with ISO treatment (CH group) and was prevented by paroxetine pre-treatment (CH + P group) ( n = 6 per group). Serum levels of inflammatory biomarkers IL6 ( n = 4) ( B ) and CRP ( n = 6) ( C ) increased with ISO treatment (CH group) and were prevented by paroxetine and fluoxetine pre-treatment (CH + P and CH + F groups). All data are expressed as mean ± SEM. Differences between groups were detected using one-way ANOVA followed by Dunnett’s post hoc test. Statistically significant differences between groups are shown as * p < 0.05, *** p < 0.001. CH: cardiac hypertrophy untreated; CH + P: cardiac hypertrophy pretreated with paroxetine; CH + F: cardiac hypertrophy pretreated with fluoxetine; NFκB: Nuclear factor-kappa-light-chain-enhancer of activated B-cells; IL6: interleukin 6; CRP: C-reactive protein.
Mouse Monoclonal Anti–Nfκb P65 Subunit Antibody, supplied by Chemicom Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antinf%CE%BAb/mouse+monoclonal+anti+nf%CE%BAb+p65+subunit+antibody/10__3171_slash_2009__9__jns09329-48-21-24
Average 90 stars, based on 1 article reviews
mouse monoclonal anti–nfκb p65-subunit antibody - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
anti-nfκb-p65 (phospho-ser311) antibody clone 11260  (SunBio Inc)
90
SunBio Inc anti-nfκb-p65 (phospho-ser311) antibody clone 11260
Effect of paroxetine on ISO-induced NF-κB and inflammatory biomarkers. ( A ) Level of <t>NFκB(p105)</t> in myocardium tissues increased with ISO treatment (CH group) and was prevented by paroxetine pre-treatment (CH + P group) ( n = 6 per group). Serum levels of inflammatory biomarkers IL6 ( n = 4) ( B ) and CRP ( n = 6) ( C ) increased with ISO treatment (CH group) and were prevented by paroxetine and fluoxetine pre-treatment (CH + P and CH + F groups). All data are expressed as mean ± SEM. Differences between groups were detected using one-way ANOVA followed by Dunnett’s post hoc test. Statistically significant differences between groups are shown as * p < 0.05, *** p < 0.001. CH: cardiac hypertrophy untreated; CH + P: cardiac hypertrophy pretreated with paroxetine; CH + F: cardiac hypertrophy pretreated with fluoxetine; NFκB: Nuclear factor-kappa-light-chain-enhancer of activated B-cells; IL6: interleukin 6; CRP: C-reactive protein.
Anti Nfκb P65 (Phospho Ser311) Antibody Clone 11260, supplied by SunBio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antinf%CE%BAb/anti+nf%CE%BAb+p65++phospho+ser311++antibody+clone+11260/10__3920_slash_bm2017__0035-98-19-24
Average 90 stars, based on 1 article reviews
anti-nfκb-p65 (phospho-ser311) antibody clone 11260 - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier
mouse monoclonal anti-nfκb (p65)  (ImmunoGen Inc)
90
ImmunoGen Inc mouse monoclonal anti-nfκb (p65)
Effect of paroxetine on ISO-induced NF-κB and inflammatory biomarkers. ( A ) Level of <t>NFκB(p105)</t> in myocardium tissues increased with ISO treatment (CH group) and was prevented by paroxetine pre-treatment (CH + P group) ( n = 6 per group). Serum levels of inflammatory biomarkers IL6 ( n = 4) ( B ) and CRP ( n = 6) ( C ) increased with ISO treatment (CH group) and were prevented by paroxetine and fluoxetine pre-treatment (CH + P and CH + F groups). All data are expressed as mean ± SEM. Differences between groups were detected using one-way ANOVA followed by Dunnett’s post hoc test. Statistically significant differences between groups are shown as * p < 0.05, *** p < 0.001. CH: cardiac hypertrophy untreated; CH + P: cardiac hypertrophy pretreated with paroxetine; CH + F: cardiac hypertrophy pretreated with fluoxetine; NFκB: Nuclear factor-kappa-light-chain-enhancer of activated B-cells; IL6: interleukin 6; CRP: C-reactive protein.
Mouse Monoclonal Anti Nfκb (P65), supplied by ImmunoGen Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/antinf%CE%BAb/mouse+monoclonal+anti+nf%CE%BAb++p65+/pm20107922-33-18-22
Average 90 stars, based on 1 article reviews
mouse monoclonal anti-nfκb (p65) - by Bioz Stars, 2026-08
90/100 stars
  Buy from Supplier

Image Search Results


Effect of paroxetine on ISO-induced NF-κB and inflammatory biomarkers. ( A ) Level of NFκB(p105) in myocardium tissues increased with ISO treatment (CH group) and was prevented by paroxetine pre-treatment (CH + P group) ( n = 6 per group). Serum levels of inflammatory biomarkers IL6 ( n = 4) ( B ) and CRP ( n = 6) ( C ) increased with ISO treatment (CH group) and were prevented by paroxetine and fluoxetine pre-treatment (CH + P and CH + F groups). All data are expressed as mean ± SEM. Differences between groups were detected using one-way ANOVA followed by Dunnett’s post hoc test. Statistically significant differences between groups are shown as * p < 0.05, *** p < 0.001. CH: cardiac hypertrophy untreated; CH + P: cardiac hypertrophy pretreated with paroxetine; CH + F: cardiac hypertrophy pretreated with fluoxetine; NFκB: Nuclear factor-kappa-light-chain-enhancer of activated B-cells; IL6: interleukin 6; CRP: C-reactive protein.

Journal: International Journal of Molecular Sciences

Article Title: Cardioprotective Effects of the GRK2 Inhibitor Paroxetine on Isoproterenol-Induced Cardiac Remodeling by Modulating NF-κB Mediated Prohypertrophic and Profibrotic Gene Expression

doi: 10.3390/ijms242417270

Figure Lengend Snippet: Effect of paroxetine on ISO-induced NF-κB and inflammatory biomarkers. ( A ) Level of NFκB(p105) in myocardium tissues increased with ISO treatment (CH group) and was prevented by paroxetine pre-treatment (CH + P group) ( n = 6 per group). Serum levels of inflammatory biomarkers IL6 ( n = 4) ( B ) and CRP ( n = 6) ( C ) increased with ISO treatment (CH group) and were prevented by paroxetine and fluoxetine pre-treatment (CH + P and CH + F groups). All data are expressed as mean ± SEM. Differences between groups were detected using one-way ANOVA followed by Dunnett’s post hoc test. Statistically significant differences between groups are shown as * p < 0.05, *** p < 0.001. CH: cardiac hypertrophy untreated; CH + P: cardiac hypertrophy pretreated with paroxetine; CH + F: cardiac hypertrophy pretreated with fluoxetine; NFκB: Nuclear factor-kappa-light-chain-enhancer of activated B-cells; IL6: interleukin 6; CRP: C-reactive protein.

Article Snippet: Paraffin-embedded heart tissue sections (5 µm) were deparaffinized and then incubated with the following primary antibodies: anti-GRK2 (1:50) (Santa Cruz Biotechnology, Santa Cruz, CA, USA), anti-IκBα(pSer32/S36) (1:100), and anti-NFκB(p105)(Ser932) (1:100) (ELK Biotechnology Co., Wuhan, China) diluted in blocking buffer [(PBS solution and 0.3% TritonX100) and 10% fetal bovine serum] at 4 °C overnight.

Techniques: